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The development of tools for the genetic manipulation of 
the causative agents of malaria - protozoan parasites of 
the  genus  Plasmodium  -  has  been  arduous  and  frus-
tratingly slow. The drive to obtain such tools is motivated 
by the ongoing public-health significance of this disease - 
malaria  remains  a  global  health  and  economic  catas-
trophe for which new drugs and an effective vaccine are 
desperately  needed,  and  if  these  are  to  be  rationally 
designed, new insights into Plasmodium biology, particu-
larly  in  understanding  the  function  of  individual  gene 
products, are in turn required. An illustration of this is 
provided by the new vaccine candidates that are arising 
from  studies  identifying  specific  parasite  antigens  as 
essential  or  important  for  red  blood  cell  invasion. 
Manipulation of the genes encoding these candidates was 
key to dissecting the relative importance and the precise 
nature of their biological roles [1]. However, progress in 
this and related endeavors has been slow, because genetic 
manipulation  of  Plasmodium  parasites  remains  labor-
ious. Indeed two issues in particular have dogged efforts 
to develop a array of robust tools to analyze gene function 
in Plasmodium: (1) low transformation efficiency where-
by very few parasites in a population receive DNA during 
an individual transfection experiment, and (2) an inability 
to use RNA interference approaches (which is an alterna-
tive to traditional transformation methods) because the 
specific RNAi machinery is lacking in this organism [2].
Nevertheless,  steady  progress  is  being  made  and  a 
range  of  molecular  genetic  approaches  to  dissect  the 
function of the 5,300 or so Plasmodium genes - including 
transgenesis,  gene  knockout,  site-directed  mutagenesis 
and knockdown of gene expression - are now available 
and have been used to good effect [3]. Such tools have 
been  developed  both  in  Plasmodium  falciparum,  the 
main cause of human malaria, and in the rodent model 
system Plasmodium berghei. In fact the development of 
tools for investigating P. berghei has often outpaced that 
for P. falciparum, largely because of the greater efficiency 
with  which  plasmid  DNA  can  be  introduced  in  this 
organism. Apart from P. berghei’s greater tractability to 
genetic  manipulation,  this  model  has  much  to  offer 
because the entire life cycle - through blood, insect-borne 
and liver stages - can be readily completed in an experi-
mental setting. This is much more difficult to achieve in 
any non-rodent system. Because many genes are shared 
across Plasmodium species and are considered ortholo-
gous,  dissection  of  gene  function  in  P.  berghei  can  be 
hugely informative to human malaria biology.
Two  major  obstacles  remain  in  the  development  of 
molecular genetic tools for Plasmodium species: the lack 
of a simple but robust system to conditionally ablate the 
function of genes essential to the blood-stage cycle and 
the lack of a highly efficient random mutagenesis system 
to  allow  classical  forward  genetic  screens  to  recover 
mutants with interesting phenotypes. A paper by Fonager 
et  al.  [4]  in  BMC  Genomics  has  made  great  strides  in 
address  ing the second of these obstacles.
What’s new?
Fonager and colleagues [4] have developed a system that 
introduces the piggyBac transposon into the genome of P. 
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cells, piggyBac has been developed as a tool for insertion 
mutagenesis  in  a  wide  range  of  systems,  including 
mammalian  cells.  DNA  elements  flanked  by  piggyBac 
sequences can insert into TTAA sequences throughout 
any genome, as long as the cells also express the piggyBac 
transposase,  the  enzyme  required  for  piggyBac  trans-
position (Figure 1).
Fonager  et  al.  [4]  build  on  earlier  successes  in  the 
Adams laboratory using the same transposon to mutate 
P.  falciparum  [5,6].  What  is  new  in  the  current  study, 
apart from the fact that the system has been modified for 
P. berghei, is the markedly improved efficiency of inser-
tion, some 16-18 times that seen in P. falciparum. In the 
P.  berghei  system,  50  or  more  insertion  events  can  be 
achieved in a single transfection. Moreover, integration 
was encouragingly random and included frequent inte-
gration into coding sequences, which was not commonly 
seen  in  P.  falciparum.  This  approach  can  there  fore  be 
used to disrupt gene expression (see Figure 1), and the 
authors demonstrate targeting by piggyBac of genes for 
proteins non-essential to blood-stage growth [4].
Another advance described is the stable integration of 
the transposase gene into the genome of P. berghei. The 
consequent  continuous  expression  of  the  transposase 
allows excision of an integrated piggyBac element and its 
reinsertion at another genomic location, thus increasing 
the potential coverage of transposon insertion resulting 
Figure 1. Use of the piggyBac transposon system to disrupt gene function and ‘trap’ promoter elements. The piggyBac transposase encoded 
by the pHTH plasmid can integrate a gene cassette (carried on the pBAC-BACII-GFP-hDHFR plasmid) flanked by piggyBac-specific inverted repeats 
into random TTAA sites within the P. berghei genome [4]. The gene cassette contains a promoter-less green fluorescent protein (gfp) gene and a 
human dihydrofolate reductase (hdhfr) selectable marker. The function of P. berghei genes can be ablated by disrupting their coding sequences or 
their promoters by insertion of the gfp-hdhfr cassette. If the cassette inserts downstream of a gene promoter (as shown here) this promoter can 
drive expression of gfp, which provides information about the timing of expression of the disrupted gene.
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features  mean  that  screening  for  genes  responsible  for 
particular  phenotypes  is  now  more  feasible  and 
practicable in Plasmodium parasites. Demonstrating the 
potential for such ‘forward genetic’ screens, Fonager et 
al. [4] show that it is possible to identify transcriptional 
promoters  in  the  P.  berghei  genome  by  ‘trapping’  a 
promoter-less  green  fluorescent  protein  marker  gene 
flanked by piggyBac elements downstream of a functional 
promoter (Figure 1).
Where to now?
So  what  is  the  potential  of  the  piggyBac  mutagenesis 
system  for  genome-wide  screens  in  P.  berghei?  For 
example, will it be possible to identify at a genome-wide 
level  all  the  genes  essential,  or  dispensable,  for  blood-
stage  growth?  To  date,  several  medium-scale  gene-
knock  out  approaches  have  been  published,  obtaining 
20-80 gene-targeting events per study [7,8]. These pro-
grams were enormously labor intensive, however, and fall 
far short of the genome-wide knockouts needed.
Another question to be asked of any new technique is 
can it identify the gene(s) responsible for a measurable 
phenotype, the genetic equivalent of finding a needle in 
haystack. Such forward genetic screens are particularly 
needed for Plasmodium parasites, in which nearly 50% of 
Plasmodium genes have no recognizable orthologs out-
side  the  genus,  as  no  previous  knowledge  about  gene 
function  is  required  [9].  In  forward  genetic  screens  in 
model  organisms,  genomes  are  generally  randomly 
mutated by radiation, chemical mutagens or insertional 
mutagenesis using transposons, after which mutants are 
identified  by  phenotypic  assay  and  the  phenotype  tied 
back to the gene that has been mutated. Such approaches 
require  mutagenesis  at  a  ‘saturation’  level  where  every 
gene  is  perturbed  in  a  single  experiment.  While  some 
progress has been made in achieving insertional muta-
genesis in Plasmodium, the systems developed to date to 
not approach the ‘saturation’ levels required.
It is probably fair to say that even with the improved 
efficiency of piggyBac insertion demonstrated by Fonager 
et  al.  [4],  this  system  still  falls  short  of  a  ‘saturating’ 
mutagenesis  procedure  that  could  be  easily  used  for 
screens. The authors estimate that up to 50 transfection 
experiments would need to be performed to achieve this 
level of integration. Most promise for the future probably 
lies  in  further  improvements  to  the  re-mobilization 
approach demonstrated by Fonager et al., in which the 
transposase  remains  expressed  in  the  parasite  cell  and 
facilitates the transposition of piggyBac from one inser-
tion site to another. More frequent and controllable re-
mobilization  is  probably  required  to  make  such  an 
approach effective in achieving frequent insertion events. 
Perhaps this could be achieved by higher-level expression 
of the transposase and by controlling expression of the 
transposase  with  a  conditionally  regulatable  system. 
Several methods for doing this are now emerging.
Because  parasites  are  grown  and  transfected  in  the 
haploid  blood-stages,  the  piggyBac  insertion  approach 
will,  unfortunately,  only  be  useful  for  the  functional 
analysis  of  genes  that  are  not  essential  to  blood-stage 
survival, that is, it will not be possible to recover mutants 
in which piggyBac has inserted into genes that have a role 
in  blood-stage  development.  The  very  essentiality  of 
these genes is of particular interest, as they are likely to 
be  the  best  targets  for  future  drugs  and  vaccines.  To 
investigate  essential  genes  will  require  combining  the 
piggyBac system with one of the conditional expression 
systems currently available. One possibility would be to 
place  the  anhydrotetracycline  (ATc)-regulated  gene-
expression system within the piggyBac inverted terminal 
repeats [3], allowing the piggyBac-flanked ATc-regulated 
promoter  to  jump  into  and  replace  the  promoter  of  a 
random gene. The ATc-regulated promoter would be in 
the switched-on state, in case the downstream random 
gene is essential. Once parasites containing these inserted 
promoters have been cloned, the addition of ATc would 
switch off expression of the targeted gene, producing a 
rapid and observable phenotype if the gene is essential.
In summary, this work in P. berghei [4] builds on the 
less efficient piggyBac mutagenesis system developed for 
P.  falciparum  and  provides  a  clear  path  for  saturating 
genome-wide  mutagenesis  to  be  achieved  in  this 
organism.  Such  approaches  are  needed  if  the  huge 
amount of genomic information now available is to be 
dissected and exploited to produce new tools for malaria 
control.  This  need  is  as  urgent  as  ever,  given  the 
continued lack of a licensed malaria vaccine and concern 
over  the  emergence  of  parasite  strains  tolerant  to 
artemisinin derivatives [10].
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